Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
SHERMAN MICHAEL L MD
  2. Issuer Name and Ticker or Trading Symbol
RADIOLOGIX INC [RGX]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
C/O RADIOLOGIX, INC., 3600 JP MORGAN CHASE TOWER 2200 ROSS AVE
3. Date of Earliest Transaction (Month/Day/Year)
11/15/2006
(Street)

DALLAS, TX 75201
4. If Amendment, Date Original Filed(Month/Day/Year)
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $.0001 11/15/2006   D   80,773 D (1) 0 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Director Stock Option $ 12 11/15/2006   D     5,000   (2)   (10) Common Stock, par value $.0001 5,000 (10) $ 0 D  
Director Stock Option $ 12 11/15/2006   D     30,000   (3)   (10) Common Stock, par value $.0001 30,000 (10) $ 0 D  
Director Stock Option $ 12 11/15/2006   D     5,000   (4)   (10) Common Stock, par value $.0001 5,000 (10) $ 0 D  
Director Stock Option $ 3.75 11/15/2006   D     20,000   (5)   (11) Common Stock, par value $.0001 20,000 (11) $ 0 D  
Director Stock Option $ 5.3 11/15/2006   D     10,000   (6)   (10) Common Stock, par value $.0001 10,000 (10) $ 0 D  
Director Stock Option $ 13.05 11/15/2006   D     10,000   (7)   (10) Common Stock, par value $.0001 10,000 (10) $ 0 D  
Director Stock Option $ 3.52 11/15/2006   D     10,000   (8)   (12) Common Stock, par value $.0001 10,000 (12) $ 0 D  
Director Stock Option $ 4.45 11/15/2006   D     10,000   (9)   (10) Common Stock, par value $.0001 10,000 (10) $ 0 D  
Director Stock Option $ 4.3 11/15/2006   D     10,000   (9)   (13) Common Stock, par value $.0001 10,000 (13) $ 0 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
SHERMAN MICHAEL L MD
C/O RADIOLOGIX, INC.
3600 JP MORGAN CHASE TOWER 2200 ROSS AVE
DALLAS, TX 75201
  X      

Signatures

 /s/ Michael L. Sherman   11/17/2006
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Disposed of pursuant to the Agreement and Plan of Merger, dated as of July 6, 2006 (the "Merger Agreement"), by and among Radiologix, Inc. ("Radiologix") and Primedex Health Systems, Inc. ("Primedex") in exchange for a one for one exchange of Radiologix Common Stock for Primedex Common Stock and a cash payment of $144,583.67, or $1.79 per share.
(2) Fully vested as of November 20, 1998.
(3) Fully vested as of November 26, 2000.
(4) Fully vested as of January 26, 1998.
(5) Fully vested as of January 6, 2004.
(6) Fully vested as of September 19, 2002.
(7) Fully vested as of June 11, 2003.
(8) Fully vested as of June 10, 2004.
(9) This option becomes exercisable as to 1/12th of the option shares per month for 12 months.
(10) Immediately prior to the effective time of the merger, pursuant to the Merger Agreement, these options were accelerated, vested, or otherwise awarded and subsequently cancelled without any exchange of Radiologix Common Stock for Primedex Common Stock or cash payment.
(11) Immediately prior to the effective time of the merger, pursuant to the Merger Agreement, these options were accelerated, vested, or otherwise awarded and subsequently exchanged for a cash payment of $13,600, or $0.68 per share.
(12) Immediately prior to the effective time of the merger, pursuant to the Merger Agreement, these options were accelerated, vested, or otherwise awarded and subsequently exchanged for a cash payment of $9,100, or $0.91 per share.
(13) Immediately prior to the effective time of the merger, pursuant to the Merger Agreement, these options were accelerated, vested, or otherwise awarded and subsequently exchanged for a cash payment of $1,300, or $0.13 per share.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.